<DOC>
	<DOCNO>NCT00749619</DOCNO>
	<brief_summary>Addition Heparin Catheter Lock Solution ( CLS ) : Taurolock-TM improve vascular patency compare Taurolock-TM alone , hemodialysis patient Tunneled Cuffed Catheter ( TCC ) vascular access .</brief_summary>
	<brief_title>Addition Heparin Taurolock-TM CLS HD Patients With TCC Dose Improve Catheter Patency Problems ?</brief_title>
	<detailed_description>Bacteremia thrombosis major complication TCC use hemodialysis.Instilation CLS contain antibiotic-anticoagulant solution end dialysis session till next dialysis , prevent Catheter relate bacteremia ( CRB ) .In previous study department , Taurolock-TM decrease rate CRB increase incidence catheter malfunction . The aim study investigate influence Heparin addition CLS-Taurolock- TM ( Taurolidine &amp; citrate 4 % ) prevention catheter patency problem HD patient TCC , addition CRB prevention . Methods : Patients newly insert TCC HD enrol randomize receive one three CLS type : group 1- Taurolock-TM , Group 2 - Taurolock-TM Heparin , Group 3- Heparin .Patients follow 6 monthes . The objective study investigate effect Taurolock TM heparin rate CRB vascular patency .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Taurolidine</mesh_term>
	<criteria>Hemodialysis patient new TCC Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Tunneled Cuffed Catheter</keyword>
	<keyword>Catheter Lock Solution</keyword>
	<keyword>Catheter Related Bacteremia</keyword>
</DOC>